Evidence map›Paper›PMID 29669837›Full record

ArticleJournal of virology2018

Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8

Hadi Karimzadeh, Muthamia M Kiraithe, Anna D Kosinska, Manuel Glaser, Melanie Fiedler, Valerie Oberhardt, Elahe Salimi Alizei, Maike Hofmann, Juk Yee Mok, Melanie Nguyen and 23 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Hepatitis Delta Virus and Hepatocellular Carcinoma.Pathogens (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Liver-Resident Bystander CD8Gastroenterology · 2021
    Article
  10. Review
  11. Review
  12. Human hepatitis D virus-specific T cell epitopes.JHEP reports : innovation in hepatology · 2021
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Hepatitis D Virus-Specific CD8Gastroenterology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 16 institutions in 5 countries.

Hadi KarimzadehInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Munich, Germany.
Muthamia M KiraitheUniversity Hospital Freiburg, Department of Medicine II, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Anna D KosinskaInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Munich, Germany.
Manuel GlaserCenter for Integrated Protein Science Munich at the Department of Biosciences, Technische Universität München, Freising, Germany.
Melanie FiedlerInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.
Valerie OberhardtUniversity Hospital Freiburg, Department of Medicine II, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Elahe Salimi AlizeiUniversity Hospital Freiburg, Department of Medicine II, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Maike HofmannUniversity Hospital Freiburg, Department of Medicine II, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Juk Yee MokSanquin, Amsterdam, The Netherlands.
Melanie NguyenSanquin, Amsterdam, The Netherlands.
Wim J E van EschSanquin, Amsterdam, The Netherlands.
Bettina BudeusDepartment of Bioinformatics, University of Duisburg-Essen, Essen, Germany.
Jan GrabowskiGerman Center for Infection Research (DZIF), Munich and Hannover Sites, Braunschweig, Germany.
Maria HomsCIBERehd and Departments of Biochemistry/Microbiology and Hepatology, Vall d'Hebron Hospital, University Autònoma de Barcelona (UAB), Barcelona, Spain.
Antonella OliveroDepartment of Medical Sciences, University of Turin, Turin, Italy.
Hossein KeyvaniDepartment of Virology, Iran University of Medical Sciences, Tehran, Iran.
Francisco Rodríguez-FríasCIBERehd and Departments of Biochemistry/Microbiology and Hepatology, Vall d'Hebron Hospital, University Autònoma de Barcelona (UAB), Barcelona, Spain.
David TaberneroCIBERehd and Departments of Biochemistry/Microbiology and Hepatology, Vall d'Hebron Hospital, University Autònoma de Barcelona (UAB), Barcelona, Spain.
Maria ButiCIBERehd and Departments of Biochemistry/Microbiology and Hepatology, Vall d'Hebron Hospital, University Autònoma de Barcelona (UAB), Barcelona, Spain.
Andreas HeinoldInstitute of Transfusion Medicine, University of Duisburg-Essen, University Hospital, Essen, Germany.
Seyed Moayed AlavianBaqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Tanja BauerInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Munich, Germany.
Julian Schulze Zur WieschDepartment of Medicine, Section of Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bijan RaziorrouhUniversity Hospital Munich-Grosshadern, Department of Medicine II, Munich, Germany.
Daniel HoffmannDepartment of Bioinformatics, University of Duisburg-Essen, Essen, Germany.
Antonina SmedileDepartment of Medical Sciences, University of Turin, Turin, Italy.
Mario RizzettoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Heiner WedemeyerGerman Center for Infection Research (DZIF), Munich and Hannover Sites, Braunschweig, Germany.
Jörg TimmInstitute of Virology, Heinrich-Heine-University, University Hospital, Duesseldorf, Germany.
Iris AntesCenter for Integrated Protein Science Munich at the Department of Biosciences, Technische Universität München, Freising, Germany.
Christoph Neumann-HaefelinUniversity Hospital Freiburg, Department of Medicine II, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Ulrike ProtzerInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Munich, Germany.
Michael RoggendorfInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Munich, Germany michael.roggendorf@tum.de.
University of Duisburg-Essen · DECentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESHelmholtz Zentrum München · DESanquin · NLUniversity Medical Center Freiburg · DEUniversity of Turin · ITTechnical University of Munich · DEUniversity of Freiburg · DEBaqiyatallah University of Medical Sciences · IRCenter for Integrated Protein Science Munich · DEDüsseldorf University Hospital · DEGerman Center for Infection Research · DEIran University of Medical Sciences · IRMedizinische Hochschule Hannover · DEMünchen Klinik · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Virus-specific CD8 T cell response seems to play a significant role in the outcome of hepatitis delta virus (HDV) infection. However, the HDV-specific T cell epitope repertoire and mechanisms of CD8 T cell failure in HDV infection have been poorly characterized. We therefore aimed to characterize HDV-specific CD8 T cell epitopes and the impacts of viral mutations on immune escape. In this study, we predicted peptide epitopes binding the most frequent human leukocyte antigen (HLA) types and assessed their HLA binding capacities. These epitopes were characterized in HDV-infected patients by intracellular gamma interferon (IFN-γ) staining. Sequence analysis of large hepatitis delta antigen (L-HDAg) and HLA typing were performed in 104 patients. The impacts of substitutions within epitopes on the CD8 T cell response were evaluated experimentally and by

Indexed as

Amino Acid SequenceAmino Acid SubstitutionCD8-Positive T-LymphocytesEpitopes, T-LymphocyteHepatitis DHepatitis delta AntigensHepatitis Delta VirusHLA-B AntigensHumansMutationSequence HomologyEpitopes, T-LymphocyteHepatitis delta Antigenshepatitis delta virus large antigenHLA-B Antigenscytotoxic T lymphocyteepitope mappingimmune escapeimmune selectionlarge hepatitis delta antigen

Identifiers

PMID29669837
PMCPMC6002722
OpenAlexW2802924774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.